ABSTRACT Introduction: Type 2 diabetes mellitus (DM2) and arterial hypertension (HTA) correspond to the group of non-communicable chronic diseases (NCDs) that have occurred most frequently worldwide. Patients suffering from DM2 with or without AHT have unhealthy lifestyles, which must be studied using standardized instruments. Objective: To evaluate the risk factors in patients with DM2 with and without AHT who attend the diabetic club of the health center of the Santa Ana canton in the parish of Lodana in the province of Manabí, Ecuador, from October 2021 to March. 2022. Methodology: A descriptive, cross-sectional observational study was carried out. Consecutive non-probabilistic sampling was used, obtaining 44 patients who met the inclusion criteria. The sample was divided into 2 groups: 34 patients with DM2 and 10 patients with DM2 and HTA. Two questionnaires were applied to both groups: one on sociodemographic characteristics and the IMEVID questionnaire. For the processing and analysis of the information, a record sheet was prepared in Excel with the information obtained from the applied questionnaires. The results were expressed in relative frequency and percentages. Results: Regarding the sociodemographic characteristics, it was evidenced that in both groups the married marital status and primary schooling predominated. In relation to occupation, the patients of the DM2 group stated that they dedicated themselves to housework and the patients of the DM2 and HTA group were active at work. Regarding lifestyle, the dimensions corresponding to nutrition, physical activity, smoking, and alcoholism were evaluated. Similar results were obtained in both groups studied. Conclusion: The lifestyle followed most frequently in both groups of patients was that related to bad eating habits and sedentary tendencies.

RESUMEN Introducción: la diabetes mellitus tipo 2 (DM2) y la hipertensión arterial (HTA) corresponden al grupo de enfermedades crónicas no transmisibles (ECNT) que se han presentado con mayor frecuencia a nivel mundial. Los pacientes que padecen DM2 con o sin HTA presentan estilos de vida poco saludables, que deben ser estudiados a través de instrumentos estandarizados. Objetivos: evaluar los factores de riesgo en pacientes con DM2 con y sin HTA que acuden al club de diabéticos del centro de salud del cantón Santa Ana en la parroquia de Lodana de la provincia de Manabí, Ecuador, en el período de octubre 2021 a marzo 2022. Metodología: se realizó un estudio observacional descriptivo, transversal. Se empleó un muestreo no probabilístico consecutivo obteniendo 44 pacientes que cumplían los criterios de inclusión. La muestra fue dividida en 2 grupos: 34 pacientes con DM2 y 10 pacientes con DM2 y HTA. A ambos grupos se les aplicó dos cuestionarios: uno sobre las características socio demográficas y el cuestionario IMEVID. Para el procesamiento y análisis de la información se elaboró una hoja de registro en Excel con la información obtenida de los cuestionarios aplicados. Los resultados fueron expresados en frecuencia relativa y porcentajes. Resultados: respecto a las características sociodemográficas se evidenció que en ambos grupos predominó el estado civil casado y la escolaridad primaria. En relación con la ocupación los pacientes del grupo DM2 manifestaron dedicarse a las labores del hogar y los pacientes del grupo DM2 y HTA son activos laboralmente. En cuanto al estilo de vida, se evaluaron las dimensiones correspondientes a nutrición, actividad física, tabaquismo, alcoholismo. Se obtuvieron resultados similares en ambos grupos estudiados. Conclusión: el estilo de vida llevado con mayor frecuencia en ambos grupos de pacientes es aquel relacionado a malos hábitos alimenticios y tendencias sedentarias.

Background Chile has one of the highest mortality rates by gastric cancer (GC) worldwide. Primary prevention of GC and detection of pre-neoplastic and early neoplastic lesions should be a national priority. Aim To assess the impact of the protocolization of endoscopy referral and the use of H. pylori stool antigen test (HPSA) in the management of dyspepsia to decrease the waiting list for endoscopy and increase the detection of gastric pre-neoplastic and early neoplastic lesions. Material and Methods We included all patients referred to the Endoscopy Unit of a regional hospital, from January 2015 to December 2017. We also included patients with known pre-neoplastic lesions and all those with first degree relatives with GC. We implemented protocols for referral of patients with dyspepsia considering the use of HPSA test, prioritizing to endoscopy those with a higher risk of GC. Results A total of 4,641 endoscopies and 2,631 HPSA tests were carried out. After the adoption of these protocols, we observed a 52% decrease in the waiting time for endoscopy. The GC detection rate in this period was 1.8 to 3.1 cases per 100 endoscopies. After the adoption of the protocols, we observed a significant increase in early GC detection rate (from none in 2015 to 13% in 2017, p = 0.03). Conclusions The protocolization of the referral for endoscopy associated with widespread use of HPSA test in the management of patients with dyspepsia, are successful strategies to decrease waiting lists for endoscopy and optimize the detection rate of pre-neoplastic lesions and early GC.

RESUMEN La neurotransmisión dopaminérgica interviene en los mecanismos que involucran los procesos motores, cognoscitivos, conductuales y neurocrinos y su mal funcionamiento la involucra en los trastornos neurodegenerativos que afectan al sistema nervioso central (SNC), tales como en la enfermedad de Parkinson y la enfermedad de Huntington, entre otras. Con el propósito de encontrar una solución terapéutica a estas patologías, en publicaciones anteriores hemos reportado la síntesis, la evaluación farmacológica y el estudio teórico computacional de los compuestos análogos mono y dihidroxilados (sobre el anillo indano) del N-aralquil-2-aminoindano 4-8, análogos 4,7-dimetoxi-2-aminoindano-N-aralquil, bajo sus formas metoxiladas sobre el anillo bencénico del fragmento aralquil 9 y el derivado fenólico 10, así como también los análogos diclorados del N-aralquil-2-aminoindano 11 con actividades dopaminérgicas centrales. En el presente trabajo se sintetizaron los clorhidratos del 2-aminoindano- N-[2-(mono o dimetoxi)-fenil)-1-metil-etil] 12-15 y su evaluación farmacológica mostraron respuestas agonísticas como potenciales agentes antihuntington y antipárkinson.

SUMMARY Dopaminergic neurotransmission is implicated in mechanisms that involve motor, cognoscitive, conductual and neurocrine process, and its malfunction involucrates it in neurodegenerative disorders affecting central nervous system (CNS), like Parkinson's disease and Huntington's disease, among others. On the purpose of finding some therapeutic for these pathologies, in previous researches we have reported synthesis, pharmacological evaluation and theoretical computational study of compounds analogues mono or di hydroxilated (on indane ring) of N-aralkyl-2-aminoindane 4-8, analogues 4,7-dimethoxy-2-aminoindane-N-aralkyl, under its methoxylated forms on benzene ring of aralkyl fragment 9 and phenolic derivate 10, also dichlorade analogs of N-aralkyl-2-aminoindane 11 with central dopaminergic activities. In this work were synthesized hydrochlorides of 2-aminoindane-N-[(mono or di methoxy)-phenyl-1-methyl-ethyl] (12-15) and its pharmacologic evaluation showed agonistic responses as potential agents anti Huntington and/or anti Parkinson.

The goal of this study was to demonstrate the usefulness of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of pulmonary tuberculosis (PTB) and extrapulmonary TB (EPTB). This assay used 20 amino acid-long, non-overlapped synthetic peptides that spanned the complete Mycobacterium tuberculosis ESAT-6 and Ag85A sequences. The validation cohort consisted of 1,102 individuals who were grouped into the following five diagnostic groups: 455 patients with PTB, 60 patients with EPTB, 40 individuals with non-EPTB, 33 individuals with leprosy and 514 healthy controls. For the PTB group, two ESAT-6 peptides (12033 and 12034) had the highest sensitivity levels of 96.9% and 96.2%, respectively, and an Ag85A-peptide (29878) was the most specific (97.4%) in the PTB groups. For the EPTB group, two Ag85A peptides (11005 and 11006) were observed to have a sensitivity of 98.3% and an Ag85A-peptide (29878) was also the most specific (96.4%). When combinations of peptides were used, such as 12033 and 12034 or 11005 and 11006, 99.5% and 100% sensitivities in the PTB and EPTB groups were observed, respectively. In conclusion, for a cohort that consists entirely of individuals from Venezuela, a multi-antigen immunoassay using highly sensitive ESAT-6 and Ag85A peptides alone and in combination could be used to more rapidly diagnose PTB and EPTB infection.